Products & Solutions
Back
Products & Solutions
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Protein Chemistry
Workflow & Informatics
Automation Systems Clinical Information Management Tools PROService Remote Service Tool DxONE Inventory Manager Instrument Aggregator Middleware Data Analytics
Solutions For
SARS-CoV-2 Antibody Testing Anemia Cardiovascular Disease Diabetes Diagnostics Drug Monitoring & Detection Prostate Cancer Detection Reproductive Health Sepsis Life Sciences ›
Service promo banner
Support
Back
Support
Account Support
Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Training Courses › Register for Training ›
Education & Research
Webinars Posters 3D Virtual Laboratory Showcase
Insights
Clinical Studies & Trends Case Studies Publications
Lab order management systems
Company
Back
Company
People & Culture
Overview Meet Our Teams Diversity + Inclusion How We Work Innovation
Careers
Job Search › Career Stories Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Resources / Webinars / Hematology and Sepsis Webinars / Clinical Utility of DxH 900 Hematological Parameters

Clinical Utility of DxH 900 Hematological Parameters

In this on-demand webinar, Dr. Maite Serrando, MD, PhD and Dr. Alba Herraiz Ruiz share their experience with the clinical utility of DxH 900 technology and its hematological parameters. They discuss the power of near-native cell characterization as well as the performance of Monocyte Distribution Width (MDW) as a severity of infection marker.

 

Related resources:

Understanding Acute Myeloid Leukemia

Clinical Studies CBC-Diff Results Coupled with PBS Review May Suggest AML

Learn how the DxH 900 & 690T hematology analyzer with its advanced theory of operation and near-native cellular characterization provided clinically significant data that helped to raise the index of suspicion of acute myeloid leukemia.

Read study
Digital Hematology: Advanced Technology Guide

Casebook Digital Hematology: Advanced Technology Guide

With its advanced theory of operation and near-native cellular characterization, DxH 900 & 690T hematology analyzer technology allows for effective cellular analysis to accurately analyze blood cells and provide clinically significant data to aid in disease identification. Download the casebook to learn more.

Download casebook

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.